Arbutus Biopharma (ABUS) Intangibles (2016 - 2019)
Historic Intangibles for Arbutus Biopharma (ABUS) over the last 7 years, with Q2 2019 value amounting to $43.8 million.
- Arbutus Biopharma's Intangibles fell 2525.45% to $43.8 million in Q2 2019 from the same period last year, while for Jun 2019 it was $43.8 million, marking a year-over-year decrease of 2525.45%. This contributed to the annual value of $43.8 million for FY2018, which is 2525.45% down from last year.
- According to the latest figures from Q2 2019, Arbutus Biopharma's Intangibles is $43.8 million, which was down 2525.45% from $43.8 million recorded in Q1 2019.
- Over the past 5 years, Arbutus Biopharma's Intangibles peaked at $390.0 million during Q2 2015, and registered a low of $43.8 million during Q3 2018.
- Moreover, its 5-year median value for Intangibles was $99.4 million (2016), whereas its average is $165.6 million.
- Examining YoY changes over the last 5 years, Arbutus Biopharma's Intangibles showed a top increase of 949.82% in 2016 and a maximum decrease of 7180.0% in 2016.
- Arbutus Biopharma's Intangibles (Quarter) stood at $352.6 million in 2015, then tumbled by 71.8% to $99.4 million in 2016, then crashed by 41.03% to $58.6 million in 2017, then dropped by 25.25% to $43.8 million in 2018, then changed by 0.0% to $43.8 million in 2019.
- Its last three reported values are $43.8 million in Q2 2019, $43.8 million for Q1 2019, and $43.8 million during Q4 2018.